Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
72,672,926
-
Share change
-
+279,911
-
Total reported value
-
$7,107,026,998
-
Put/Call ratio
-
132%
-
Price per share
-
$97.82
-
Number of holders
-
338
-
Value change
-
-$31,712,566
-
Number of buys
-
160
-
Number of sells
-
186
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q1 2020
As of 31 Mar 2020,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
338 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,672,926 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, Capital Research Global Investors, JANUS HENDERSON GROUP PLC, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and AMERIPRISE FINANCIAL INC.
This page lists
340
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.